IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Par Drugs and Chemicals IPO is a Fixed Price IPO listing on NSE EMERGE exchange. The company is based in Vadodara and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Par Drugs and Chemicals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th March 2019.
Par Drugs and Chemicals IPO open date is 3rd May 2019 and close date is 8th May 2019. IPO Allotment Date is 13th May 2019 and Listing date is 16th May 2019.
IPO
Size:
₹ 8.53 Cr.
Avg IPO Size (Sector Based)
: ₹
21.21 cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Pantomath Capital
SME
IPO by BRLM so far:
103
City:
Vadodara
SME
IPO so far:
22
Revenue (annualised):
₹
46.41
cr. 
PE
Ratio:
13.00x
Average Sector PE Ratio: 20.29x
Par Drugs and Chemicals IPO size is ₹ 8.53 Cr. with IPO price of ₹ 51.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Pantomath Capital Advisors Private Limited is the book-running lead manager of the Par Drugs and Chemicals IPO. Link Intime India Private Limited is the Registrar and Market Maker is Pantomath Stock Brokers Private Limited for Par Drugs and Chemicals IPO.
Par Drugs and Chemicals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Par Drugs and Chemicals IPO, based in Vadodara, operates in the Pharmaceutical sector with a focus on . The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Par Drugs and Chemicals IPO size is ₹ 8.53 Cr. with fresh issue size of ₹ 8.53 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Par Drugs and Chemicals IPO is expected to be 13th May 2019, after the finalization of basis of allotment. Investors can check Par Drugs and Chemicals IPO allotment status on the registrars website, Link Intime India Private Limited. Par Drugs and Chemicals IPO refund dates are 14th May 2019.
Par Drugs and Chemicals IPO is expected to be listed on 16th May 2019.
The upper price band for the Par Drugs and Chemicals IPO is set at ₹ 51.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Par Drugs and Chemicals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Par Drugs and Chemicals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 8th May 2019. After submission, funds are blocked until the basis of allotment of Par Drugs and Chemicals IPO is finalised.
The merchant banker for Par Drugs and Chemicals IPO is Pantomath Capital Advisors Private Limited . Pantomath Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Par Drugs and Chemicals IPO RHP for further details.
The registrar for Par Drugs and Chemicals IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Par Drugs and Chemicals IPO through their official website or helpline.
Par Drugs and Chemicals IPO was subscribed 5.74 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 8.53 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.21 Cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Pantomath Capital
SME
IPO by BRLM so far:
103
City:
Vadodara
SME
IPO so far:
22
Revenue (annualised):
₹ 46.32 cr.
PE
Ratio:
13.00x
Average Sector PE Ratio: 20.29x
Par Drugs and Chemicals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Par Drugs and Chemicals Financial Review Page
Merchant Banker(s) of Par Drugs and Chemicals IPO: Pantomath Capital Advisors Private Limited
Par Drugs and Chemicals IPO subscription was 5.74 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Par Drugs and Chemicals IPO listed at a listing price of 51.45 against the offer price of 51.00.
The current market price of Par Drugs and Chemicals is 99.41.
Why Us?
